Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
CA 19-9: Reference Range, Interpretation, Collection and Panels
Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma
Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers - ScienceDirect
Preoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinoma
Meta-Analysis of Sensitivity and Specificity for CA 19-9 and CEA | Download Table
Serum CA72-4 as a biomarker in the diagnosis of colorectal cancer: A meta-analysis
Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers - ScienceDirect
Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic Cancer - ScienceDirect
Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Diagnostic and Prognostic Value of CEA and CA19-9 in Colorectal Cancer
Download PDF | Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis
Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer - Dong - 2018 - Cancer Science - Wiley Online Library
![PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb127959fd840127d322eb4c0f3133e4069e5c6a/2-Figure1-1.png "PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar")
PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar
Download PDF | Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis
ROC curves for single detection of CEA (A) and CA 19-9 (B) and combined... | Download Scientific Diagram
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
PDF) CA 19-9 as a serum marker in urothelial carcinoma
Increased Production of CEA and CA19-9 in Systemic Lupus Erythematosus
![PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb127959fd840127d322eb4c0f3133e4069e5c6a/4-Table3-1.png "PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar")
PDF] Reference values and biological variation for tumor marker CA 19-9 in serum for different Lewis and secretor genotypes and evaluation of secretor and Lewis genotyping in a Caucasian population. | Semantic Scholar
Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer - Dong - 2018 - Cancer Science - Wiley Online Library
Clinical Efficacy of Combined Use of CEA-CA19-9 in Patients with Pancreatic Malignancy - SciAlert Responsive Version
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
